Crescent Biopharma, Inc. (CBIO)
18.51
+0.58
(+3.23%)
USD |
NASDAQ |
Sep 02, 16:00
18.51
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Market Cap : 513.76M for Sept. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 497.67M |
| August 31, 2026 | 460.75M |
| August 28, 2026 | 492.67M |
| August 27, 2026 | 492.95M |
| August 26, 2026 | 500.16M |
| August 25, 2026 | 471.85M |
| August 24, 2026 | 471.02M |
| August 21, 2026 | 476.02M |
| August 20, 2026 | 450.48M |
| August 19, 2026 | 480.73M |
| August 18, 2026 | 463.25M |
| August 17, 2026 | 485.17M |
| August 14, 2026 | 475.74M |
| August 13, 2026 | 461.58M |
| August 12, 2026 | 456.03M |
| August 11, 2026 | 463.25M |
| August 10, 2026 | 481.01M |
| August 07, 2026 | 467.41M |
| August 06, 2026 | 456.03M |
| August 05, 2026 | 437.71M |
| August 04, 2026 | 454.64M |
| August 03, 2026 | 412.73M |
| July 31, 2026 | 401.63M |
| July 30, 2026 | 416.90M |
| July 29, 2026 | 409.96M |
| Date | Value |
|---|---|
| July 28, 2026 | 456.31M |
| July 27, 2026 | 469.91M |
| July 24, 2026 | 449.42M |
| July 23, 2026 | 469.55M |
| July 22, 2026 | 436.46M |
| July 21, 2026 | 458.80M |
| July 20, 2026 | 414.96M |
| July 17, 2026 | 406.69M |
| July 16, 2026 | 416.61M |
| July 15, 2026 | 432.05M |
| July 14, 2026 | 421.99M |
| July 13, 2026 | 432.60M |
| July 10, 2026 | 478.10M |
| July 09, 2026 | 462.10M |
| July 08, 2026 | 463.48M |
| July 07, 2026 | 469.55M |
| July 06, 2026 | 467.62M |
| July 02, 2026 | 471.20M |
| July 01, 2026 | 470.93M |
| June 30, 2026 | 496.29M |
| June 29, 2026 | 496.29M |
| June 26, 2026 | 511.73M |
| June 25, 2026 | 468.45M |
| June 24, 2026 | 478.65M |
| June 23, 2026 | 482.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Encompass Health Corp. | 11.97B |
| Myriad Genetics, Inc. | 309.27M |
| BioRestorative Therapies, Inc. | 5.159M |
| U.S. Stem Cell, Inc. | 0.0634M |
| Marijuana, Inc. | 0.3956M |
Market Cap Related Metrics
| PS Ratio | 38.02 |
| Price to Book Value | 3.226 |
| Price | 18.51 |
| Earnings Yield | -41.32% |